Cargando…
Kinesin Eg5 Selective Inhibition by Newly Synthesized Molecules as an Alternative Approach to Counteract Breast Cancer Progression: An In Vitro Study
SIMPLE SUMMARY: Breast cancer is the most widespread and diagnosed cancer in women. This study tested newly synthesized Eg5 inhibitors to find valid therapeutic alternatives to common drugs able to counteract breast cancer progression. Our results evidence that thiadiazole-based Eg5 inhibitors, 2 an...
Autores principales: | Ricci, Alessia, Cataldi, Amelia, Carradori, Simone, Zara, Susi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598199/ https://www.ncbi.nlm.nih.gov/pubmed/36290354 http://dx.doi.org/10.3390/biology11101450 |
Ejemplares similares
-
Kinesin Eg5 Targeting Inhibitors as a New Strategy for Gastric Adenocarcinoma Treatment
por: Marconi, Guya Diletta, et al.
Publicado: (2019) -
Negative Modulation of the Angiogenic Cascade Induced by Allosteric Kinesin Eg5 Inhibitors in a Gastric Adenocarcinoma In Vitro Model
por: Ricci, Alessia, et al.
Publicado: (2022) -
Dual Acting Carbon Monoxide Releasing Molecules and Carbonic Anhydrase Inhibitors Differentially Modulate Inflammation in Human Tenocytes
por: Gallorini, Marialucia, et al.
Publicado: (2021) -
Lamin B Counteracts the Kinesin Eg5 to Restrain Spindle Pole Separation during Spindle Assembly
por: Goodman, Benjamin, et al.
Publicado: (2010) -
Natural and Synthetic Xanthone Derivatives Counteract Oxidative Stress via Nrf2 Modulation in Inflamed Human Macrophages
por: Gallorini, Marialucia, et al.
Publicado: (2022)